Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1979;59:133-139

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoshikawa, J.
Right arrow Articles by Baba, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoshikawa, J.
Right arrow Articles by Baba, K.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Aneurysms
*Lymphatic Diseases

Circulation, Vol 59, 133-139, Copyright © 1979 by American Heart Association


ARTICLES

Cross-sectional echocardiographic diagnosis of coronary artery aneurysms in patients with the mucocutaneous lymph node syndrome

J Yoshikawa, K Yanagihara, T Owaki, H Kato, Y Takagi, F Okumachi, T Fukaya, Y Tomita and K Baba

Real-time cross-sectional echocardiographic studies revealed the presence of coronary artery aneurysms in five patients with mucocutaneous lymph node syndrome. These lesions appeared as circular echo-free spaces with clearly-defined borders in sites corresponding to angiographically proven aneurysms. In 15 normal subjects who were studied only by noninvasive methods, and in 17 who had normal coronary arteriograms (including eight with the mucocutaneous lymph node syndrome), we found no similar echo findings. The aneurysms were in both right and left coronary arteries in three patients, and were confined to the left side in two. The mucocutaneous lymph node syndrome is an increasingly common condition in Japan which may be fatal due to myocardial infarction occurring in a setting of coronary aneurysm with thrombosis. Therefore, the ability to demonstrate coronary aneurysms noninvasively is of prognostic and potentially therapeutic value in this inadequately understood syndrome.


This article has been cited by other articles:


Home page
PediatricsHome page
J. C. Burns, H. I. Kushner, J. F. Bastian, H. Shike, C. Shimizu, T. Matsubara, and C. L. Turner
Kawasaki Disease: A Brief History
Pediatrics, August 1, 2000; 106(2): 27e - 27.
[Abstract] [Full Text]


Home page
ANGIOLOGYHome page
O. Schillaci, M. Banci, F. Scopinaro, R. Tavolaro, G. Villotti, G. De Vincentis, F. Ventriglia, M. C. Borgia, A. Centi Colella, and V. Colloridi
Myocardial Scintigraphy with 99mTc-Sestamibi in Children with Kawasaki Disease
Angiology, November 1, 1995; 46(11): 1009 - 1014.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
K. Matsumura, Y. Okuda, T. Ito, T. Hirano, K. Takeda, and N. Yamaguchi
Coronary Angiography of Kawasaki Disease with the Coronary Vasodilator Dipyridamole: Assessment of Distensibility of Affected Coronary Arterial Wall
Angiology, February 1, 1988; 39(2): 141 - 147.
[Abstract] [PDF]